- Research article
- Open Access
Mutual regulation between chicken telomerase reverse transcriptase and the Wnt/β-catenin signalling pathway inhibits apoptosis and promotes the replication of ALV-J in LMH cells
Veterinary Research volume 52, Article number: 110 (2021)
This study aimed to explore the mutual regulation between chicken telomerase reverse transcriptase (chTERT) and the Wnt/β-catenin signalling pathway and its effects on cell growth and avian leukosis virus subgroup J (ALV-J) replication in LMH cells. First, LMH cells stably overexpressing the chTERT gene (LMH-chTERT cells) and corresponding control cells (LMH-NC cells) were successfully constructed with a lentiviral vector expression system. The results showed that chTERT upregulated the expression of β-catenin, Cyclin D1, TCF4 and c-Myc. chTERT expression level and telomerase activity were increased when cells were treated with LiCl. When the cells were treated with ICG001 or IWP-2, the activity of the Wnt/β-catenin signalling pathway was significantly inhibited, and chTERT expression and telomerase activity were also inhibited. However, when the β-catenin gene was knocked down by small interfering RNA (siRNA), the changes in chTERT expression and telomerase activity were consistent with those in cells treated with ICG001 or IWP-2. These results indicated that chTERT and the Wnt/β-catenin signalling pathway can be mutually regulated. Subsequently, we found that chTERT not only shortened the cell cycle to promote proliferation but also inhibited apoptosis by downregulating the expression of Caspase 3, Caspase 9 and BAX; upregulating BCL-2 and BCL-X expression; and promoting autophagy. Moreover, chTERT significantly enhanced the migration ability of LMH cells, upregulated the protein and mRNA expression of ALV-J and increased the virus titre. ALV-J replication promoted chTERT expression and telomerase activity.
Telomerase is a ribonucleoprotein enzyme that adds tandem (TTAGGG)n repeats to the ends of chromosomes in most eukaryotes . The structure of chicken telomerase, which consists of chicken telomerase reverse transcriptase (chTERT), telomerase RNA component and telomerase-associated protein, is similar to that of human telomerase [2, 3]. Telomerase activation is considered a key step in cell carcinogenesis, and telomerase is one of the most commonly used molecular markers for a wide range of malignant tumours [4,5,6]. Studies have shown that human telomerase reverse transcriptase (hTERT) gene expression is the core determinant of telomerase activity, and overexpression of the hTERT gene is found in approximately 90% of human malignant tumours [7,8,9]. hTERT promoter activity is usually regulated by a variety of transcription factors (β-catenin, NF-κB and c-Myc), chromatin remodelling, and epigenetic methylation [10,11,12,13,14,15,16].
Avian leukosis is an infectious tumour caused by avian leukosis viruses (ALVs) belonging to the Alpharetrovirus genus of the family Retroviridae that affects poultry . Chickens infected with exogenous ALV may suffer from decreased performance and immunosuppression, leading to tumour formation and even death [18, 19]. Avian leukosis is one of the most important diseases endangering the healthy development of poultry in China. Based on the specific envelope glycoprotein (gp85) expressed, ALV in naturally infected chicken flocks can be divided into seven subgroups (A, B, C, D, E, J and K). Endogenous subgroup E viruses with little to no pathogenicity are present in nearly all chicken lines, while the viruses of the other subgroups are exogenous and pathogenic. Subgroup A and B viruses mainly cause lymphocytic leukaemia and myeloid leukosis in field flocks, while flocks naturally infected with subgroup C and D viruses are rarely observed in the field. ALV subgroup J (ALV-J) is the most pathogenic to chickens, and it is more likely than viruses in the other ALV subgroups to cause tumours in chickens [20,21,22]. Yang et al. found ALV integration in the chTERT promoter/enhancer region in B cell lymphomas, suggesting that this is a common integration site, and chTERT expression was elevated by ALV integration . Moreover, the chTERT gene was identified as a common insertion site in myeloid leukosis caused by ALV-J, and the gene expression of chTERT, a putative driver for oncogene activation, was significantly upregulated in tumour samples compared to control samples . However, it is not clear whether chTERT affects ALV-J replication and what effect ALV-J has on chTERT.
The Wnt signalling pathway is a complex signalling pathway related to cell growth and development. Abnormal activation of Wnt is closely related to the development of cardiovascular disease, hepatic fibrosis and cancer [25, 26]. The Wnt/β-catenin signalling pathway, which is considered the most common Wnt signalling pathway, plays critical roles in various cellular functions, including cell proliferation, differentiation, migration and apoptosis [27,28,29]. The significance of this pathway is exemplified by evidence that both the overexpression and underexpression of target genes involved in this pathway result in various diseases. Appropriate regulation of the Wnt/β-catenin signalling pathway is key for cells to carry out their normal functions [28, 30]. The Wnt/β-catenin signalling pathway has been implicated in the transcriptional reactivation of hTERT in cancer cells; transient activation of Wnt/β-catenin induces hTERT mRNA expression and elevates telomerase activity in different cell lines [12, 31,32,33]. Blockade of Wnt/β-catenin signalling or regulation of chTERT activation may be effective therapeutic strategies for decreasing apoptotic events in cancer cells. However, whether Wnt/β-catenin impacts chTERT remains to be investigated. Therefore, in this study, in vitro models were used to assess chTERT expression and Wnt/β-catenin signalling in the LMH cell line and to explore the effects of chTERT and Wnt/β-catenin on cell proliferation, apoptosis, and migration and ALV-J replication to lay a theoretical foundation for further elucidating the mechanism of chTERT in the tumorigenic effect of ALV-J.
Materials and methods
Anti-β-catenin and anti-c-Myc primary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Anti-TCF4 and anti-Cyclin D1 primary antibodies were purchased from Affinity Biosciences, Ltd. (USA). An anti-GAPDH primary antibody was purchased from Abcam, Inc. (UK). An anti-HA tag antibody was purchased from Invitrogen, Thermo Fisher Scientific, Inc. (California, USA). An anti-Ki67 (chicken) antibody was purchased from GeneTex, Inc. (USA). A goat anti-rabbit IgG (FITC) secondary antibody and a goat anti-mouse IgG (FITC) secondary antibody were purchased from LI-COR Biosciences, Ltd. (Nebraska, USA). Mouse monoclonal antibodies (G2.3) against the gp85 protein of ALV-J were donated by Avian Disease and Oncology Laboratory (USA).
Cell culture and viruses
The chicken hepatocellular carcinoma cell line LMH and the 293T cell line were kindly provided by Professor Ming Liao of South China Agricultural University. The chicken fibroblast cell line DF-1 was maintained in our laboratory. LMH, 293T and DF-1 cells were cultured in DMEM/F12 (Gibco, Thermo Fisher Scientific, Inc., USA) and DMEM (Gibco, Thermo Fisher Scientific, Inc.) supplemented with 10% foetal bovine serum (FBS) at 37 °C with 5% CO2. The ALV-J CHN06 strain was maintained in our laboratory.
Construction of a chTERT gene expression plasmid and a stable overexpression cell line
The full-length chTERT coding region was amplified by RT-PCR from broiler embryos (4–7 days) as two overlapping fragments (chTERT-T1 and chTERT-T2) using Phanta® Max Super-Fidelity DNA Polymerase (Vazyme, Nanjing, China). Primers were designed according to relevant literature , and the sequences are shown in Table 1. The PCR product of chTERT-T2 was amplified again to add a linker and an HA tag to the end of the DNA to generate chTERT-T2-HA. The reaction conditions were as follows: 1 cycle of 95 °C for 5 min; 35 cycles of 95 °C for 45 s, 62 °C for 30 s and 72 °C for 150 s; and 1 cycle of 72 °C for 8 min. The annealing temperature was adjusted according to the Tm value of the primer. Since there is no commercially available antibody for chTERT, the HA tag was used to measure chTERT protein levels. Then, the chTERT-T1 and chTERT-T2-HA fragments were ligated into the pLV-sfGFP(2A) (puromycin) lentiviral expression vector at the Xba I and Xho I sites with a ClonExpress®Ultra One Step Cloning Kit (Vazyme, Nanjing, China) through homologous recombination to generate pLV-chTERT-HA. Lentiviral transfection and screening were performed according to the user manual for the lentiviral gene transfer and expression system (Inovogen, Wuhan, China). Briefly, the pLV-chTERT-HA plasmid was transfected into 293T cells using PolyJet™ In Vitro DNA transfection reagent (SignaGen, Maryland, USA). At 48 to 72 h post-transfection, the lentivirus in the supernatant was harvested, filtered through a 0.45-μm filter and used to infect LMH cells. After LMH cells were infected with lentivirus containing chTERT or empty control for 48 h, puromycin was added to kill uninfected cells. Finally, LMH cells stably overexpressing the chTERT gene (LMH-chTERT cells) or control (LMH-NC cells) were obtained.
To inhibit the expression of Wnt/β-catenin and chTERT, cells were transfected with small interfering RNA (siRNA) targeting β-catenin (si-β-catenin, 5′-GCUGGUGGGAUGCAAGCUUTT-3′, 5′-AAGCUUGCAUCCCACCAGCTT-3′) or chTERT (si-chTERT, 5′-GCAUGGAACCUCCUGGCAUTT-3′, 5′-AUGCCAGGAGGUUCCAUGCTT-3’) or a nonspecific siRNA (si-NC, 5′-ACGUGACACGUUCGGAGAATT-3′, 5′-UUCUCCGAACGUGUCACGUTT-3′) (10 μmol/L) (Shanghai GenePharma Company). Cells plated in 12-well plates (100 000 cells/well) were transfected with siRNA using siRNA-Mate Transfection Reagent (GenePharma, Shanghai, China). In addition, ICG001 and IWP-2 (Beyotime, Shanghai, China) and LiCl (Sigma-Aldrich, St. Louis, Missouri, USA) were added directly to the cell culture medium to inhibit and activate Wnt/β-catenin signalling pathway activity, respectively [35,36,37]. After treatment for at least 24 h, cell viability and mRNA and protein expression were assessed by MTT assays, RT-PCR and Western blotting, respectively.
Cytotoxicity was measured using the MTT assay with an Enhanced Cell Counting Kit-8 (Beyotime). The assay was performed according to the user manual. Briefly, LMH cells were plated in 96-well plates at a density of 1 × 104 cells/well in 200 μL medium for 12 h and then treated with ICG001, IWP-2, LiCl and siRNA at different concentrations. After 72 h, CCK-8 reagent was added to the cells in the plate, the cells were incubated at 37 °C for 2 h, and the absorption was measured at 450 nm using a microplate reader (BioTek, Vermont, USA). Relative absorbance was calculated according to the following formula: cell viability = (ODtreated − ODblank)/(ODuntreated − ODblank), where OD is the optical density at 450 nm.
Real-time fluorescence quantitative PCR (RT-PCR)
Total RNA was extracted from LMH cells by using TRIzol reagent (Fastagen Biotech, Shanghai, China) according to the manufacturer’s recommendations. First-strand cDNA was synthesized from 500 ng of total RNA template with random primers using a PrimeScript RT Reagent kit (TaKaRa, Japan). RT-PCR was performed using Hieff® qPCR SYBR Green Master Mix (YEASEN, Shanghai, China) on the CFX96™ Real-time PCR System (Bio-Rad, California, USA). Expression levels were quantified using the 2−ΔΔCt method and normalized to GAPDH expression. All the primer sequences are shown in Table 2.
Protein was extracted from LMH cells using Fierce RIPA Lysis Buffer (Beyotime) following the manufacturer’s instructions. Briefly, equal amounts of total protein were separated by SDS–polyacrylamide gel electrophoresis (SDS-PAGE) (Beyotime) and then transferred onto a polyvinylidene difluoride (PVDF) membrane. The membranes were immunoblotted with primary antibodies at 4 °C overnight, followed by incubation with a fluorescein isothiocyanate-conjugated secondary antibody at 37 ℃ for one hour. Finally, the blots were scanned using an Odyssey Infrared Imaging System (LI-COR, Nebraska, USA).
Telomerase activity assay
Telomerase activity was measured by the telomeric repeat amplification protocol (TRAP), which was conducted with the TeloTAGGG Telomerase PCR ELISA Kit (Sigma-Aldrich) following the manufacturer’s protocol. A total of 2 × 105 cells were transferred to an Eppendorf tube and centrifuged. The pellet was resuspended in lysis buffer (200 μL) and incubated for 30 min on ice, and then, the supernatant was collected and transferred to a fresh tube. A total of 25 μL reaction mixture was transferred to an amplification tube, and 23 μL PCR-grade water and 2 μL sample or positive (293T cell lysate) or negative (DF-1 cell lysate) control were added to obtain a 50-μL PCR system. Amplification was performed on a PCR instrument (Applied Biosystems, Foster City, CA, USA) under the following conditions: 1 cycle of 25 ℃ for 20 min; 1 cycle of 94 ℃ for 5 min; 30 cycles of 94 ℃ for 30 s, 50 ℃ for 30 s and 72 °C for 90 s; and 1 cycle of 72 ℃ for 10 min. Then, 20 μL denaturation reagent and 5 μL amplification products were added sequentially to the tube, and the mixture was incubated for 10 min at room temperature. Hybridization buffer (225 μL) was added, followed by thorough mixing, and 100 μL of the mixture was transferred to each microplate well and incubated for 2 h at 37 °C. After 3 washes, anti-DIG-POD working solution (100 μL) was added, and the samples were incubated for 30 min at room temperature. Then, after 5 washes, TMB substrate solution (100 μL) was added and incubated for 15 min at room temperature. Finally, 100 μL top reagent was added, and the absorbance at 450 nm was measured within 15 min.
Cell proliferation, apoptosis and cell cycle were analysed by flow cytometry using the BeyoClick™ EdU Cell Proliferation Kit with Alexa Fluor 647 (Beyotime), Annexin V-APC Apoptosis Analysis Kit (Sungene Biotech, Tianjin, China) and Cell Cycle Kit (Beyotime), respectively, according to the manufacturer’s protocol. Cells were acquired on a CytoFLEX flow cytometer (Beckman Coulter, Florida, USA), and data were analysed by FlowJo software (Tree Star, Inc., Ashland, OR, USA).
Apoptosis was analysed by immunofluorescence using a One Step TUNEL Apoptosis Assay Kit (Beyotime) according to the manufacturer’s protocol. Cell proliferation was also analysed by Ki67 immunofluorescence. Seventy-two hours after LMH-chTERT and LMH-NC cells were plated in 6-well plates at a density of 1 × 105 cells/well, the cells were fixed with 3% formaldehyde and 2% sucrose in PBSA and then permeabilized with 0.1 M glycine. The cells were blocked with 2% normal goat serum and 0.4% Triton X-100 in PBSA for 30 min and incubated overnight with primary antibody. After being washed with 0.2% Triton X-100 in PBSA, the cells were incubated with Cy3-labelled goat anti-rabbit IgG secondary antibody, and DAPI was used for nuclear visualization. Images were captured using a Nikon Ti2 microscope and Nikon camera.
Transmission electron microscopy (TEM)
LMH cells were plated into 6-well cell culture plates, incubated for 24 h, harvested, and fixed in 2.5% glutaraldehyde for 24 h at 4 °C. Subsequently, the cells were rinsed with buffer, fixed with citric acid, and dehydrated in a series of ethanol solutions. Then, the cells were permeabilized in different ratios of ethanol: resin and embedded in pure resin, which was polymerized at 70 °C. The stained cells were visualized using a transmission electron microscope (Hitachi, Ltd., Japan) to observe various structures within the cells.
Wound healing assay
Cell culture inserts (Ibidi, Martinsried, Germany) were placed in 6-well plates, and LMH cells were plated on the inserts. After the cell density reached 100%, the inserts were removed, a wound was created, the supernatant was discarded, and Opti-MEM (Gibco, California, USA) without serum was added to culture the cells. After 24 and 48 h, the cells were imaged with a Nikon Eclipse Ti2 microscope, and the pixel area of the wound gap was calculated using ImageJ v1.49 (NIH, USA). The migration rate (MR) was calculated as (initial pixel area (0 h)-terminal pixel area (24 h or 48 h))/initial pixel area (0 h) × 100%.
Enzyme-linked immunosorbent assay (ELISA) for ALV p27
Cells infected with ALV-J CHN06 at a multiplicity of infection (MOI) of approximately 0.1 were incubated at 37 °C with 5% CO2 for 7 days. Then, ALV group-specific p27 antigen levels in the cell culture supernatant were measured with an Avian Leukosis Virus Antigen Test Kit (IDEXX Laboratories Pty., Ltd., Westbrook, USA) according to the manufacturer’s protocol. Briefly, samples and positive and negative controls (100 μL) were added to the wells of ELISA plates, incubated at room temperature for 60 min, and then washed three to five times with 350 μL/well washing buffer. Then, 100 μL HRP-conjugated rabbit antibody against p27 was added to all the wells, and the plate was incubated for another 60 min. After 3–5 washes, 100 μL substrate solution was added for colour development for 15 min, and the reaction was stopped by adding 100 μL stop solution to each well. The absorbance at 650 nm was measured using a microplate reader (BioTek). The expression level of ALV p27 was determined by calculating the S/P value: [(mean sample OD) − (mean negative control OD)]/[(mean positive control OD) − (mean negative control OD)].
The TCID50 assay was used to evaluate the virus titre. DF-1 cells were cultured in 96-well plates at a density of 4 × 104 cells per well. A tenfold serially diluted virus sample was added to each well in a volume of 100 μL (eight replicates for each sample) and incubated for 2 h. Then, the supernatant was discarded, fresh DMEM containing 1% FBS was added, and the cells were incubated for 7 continuous days at 37 °C in 5% CO2. ELISAs for ALV p27 were performed. The TCID50 was calculated using the Reed-Muench method.
All the results are presented as the mean ± standard deviation. Statistical analysis was performed by Student’s t test using GraphPad 5 software. A p value of < 0.05 was considered significant. *, **, *** and **** indicate p values less than 0.05, 0.01, 0.001 and 0.0001, respectively.
Cloning of the chTERT gene
The chTERT gene, which is approximately 4000 bp in length, was obtained by PCR as described in the Methods. The results of agarose gel electrophoresis of the amplification products for the chTERT-T1, chTERT-T2 and chTERT-T2-HA fragments and the double restriction digestion of the pLV-chTERT-HA plasmid are shown in Additional file 1. The recombinant plasmids were sent to Sangon Biological (Shanghai, China) for sequencing, and the results showed that the full-length coding sequence of chTERT was 4097 bp long and was predicted to encode a protein of 1346 amino acids (aa). The aa sequence of the protein was nearly identical to that of the Gallus gallus TERT sequence [GenBank: NM_001031007.1] except for one transition mutation (a V-I mutation at aa 326 and an R-H mutation at aa 384).
Stable overexpression of the chTERT gene in LMH cells
The pLV-chTERT-HA and pLV-NC plasmids were used to infect LMH cells. After repeated screening with puromycin, LMH cells stably overexpressing the chTERT gene (LMH-chTERT cells) and negative control cells (LMH-NC cells) were obtained. The results showed that the mRNA and protein expression levels of chTERT were significantly higher in LMH-chTERT cells than in control cells (Figure 1A; p < 0.0001). Although LMH cells were telomerase positive, the expression level of chTERT was extremely low. In addition, telomerase activity in LMH-chTERT cells was significantly higher than that in control cells (Figure 1B; p < 0.01) but lower than that in 293 T cells, which were regarded as positive controls. DF-1 cells, which do not exhibit telomerase activity, were used as negative controls.
Cytotoxic effects of LiCl, ICG001, IWP-2 and siRNA on LMH cells
To determine the concentration range at which the investigated inhibitors and siRNAs suppress β-catenin-dependent gene or chTERT gene expression without markedly affecting cell viability, the cytotoxic effects of Wnt/β-catenin signalling pathway inhibitors (ICG001 and IWP-2) and siRNAs (si-β-catenin and si-chTERT) were assessed by MTT assays. The cytotoxicity of a Wnt/β-catenin signalling pathway activator (LiCl) was also tested. For functional testing, the cells were incubated with an inhibitor or activator at different concentrations for 24, 36, or 72 h. Similarly, LMH cells were transfected with different concentrations of siRNA for 24, 36, or 72 h. Over a wide range of concentrations, ICG001, IWP-2, LiCl and siRNAs decreased cell viability in a dose-dependent manner. The reduction in LMH cell viability was not significantly different from that observed in the control group when ICG001 was administered at concentrations ≤ 5 μM, time had no obvious influence on cell viability at these concentrations (Figure 2A), and similar results were obtained with IWP-2 (Figure 2B). At a concentration of ≥ 20.0 μM, LiCl significantly decreased the viability of LMH cells; however, at 5.0 and 10.0 mM, LiCl significantly increased cell viability, and the effect of 5 mM LiCl was stronger than that of 10 mM LiCl (Figure 2C). In addition, both β-catenin siRNA and chTERT siRNA exhibited significant cytotoxicity at concentrations ≥ 75 nM (Figures 2D and E). Therefore, the optimal concentrations of ICG001, IWP-2, LiCl and siRNAs were 5 μM, 5 μM, 5 mM and 50 nM, respectively; these concentrations were used in subsequent experiments.
chTERT activated the Wnt/β-catenin signalling pathway overexpression
The Western blot and RT-PCR results showed that chTERT significantly increased β-catenin protein expression, which was higher in LMH-chTERT cells than in LMH-NC cells. The overexpression of chTERT also significantly increased the expression of downstream target genes, such as cyclin D1, the transcription factor TCF4 and the tumour-related factor c-Myc (Figures 3A and B; p < 0.05). These results indicated that chTERT can activate the Wnt/β-catenin signalling pathway and affect cell growth.
The β-catenin signalling pathway regulated chTERT expression and telomerase activity
To further verify the regulatory effect of chTERT on the Wnt/β-catenin signalling pathway, si-chTERT was used to interfere with chTERT expression in LMH-chTERT cells, and Wnt/β-catenin signalling pathway activity was determined at 72 h. In addition, to explore whether the Wnt/β-catenin signalling pathway can regulate the expression of chTERT, LMH-chTERT cells were treated with inhibitors (ICG001 and IWP-2), an activator (LiCl) or si-β-catenin for 72 h, and then, changes in chTERT expression and telomerase activity were measured by Western blotting, RT-PCR and TRAP. The results showed that when chTERT expression was inhibited by si-chTERT, β-catenin protein and mRNA expression was also inhibited, indicating that the activity of the Wnt/β-catenin signalling pathway was reduced (Figures 4A and B; p < 0.05) and that the activity of telomerase was inhibited (Figure 4C; p < 0.01). Further experiments verified that chTERT overexpression could increase the activity of the Wnt/β-catenin signalling pathway. Moreover, when cells were treated with ICG001, IWP-2 and β-catenin siRNA, the activity of the Wnt/β-catenin signalling pathway was inhibited, and the expression of chTERT was also significantly reduced (Figures 4A, D and E; p < 0.05). Similarly, telomerase activity in LMH-chTERT cells was reduced after treatment with IWP-2 (Figure 4F; p < 0.01). In contrast, the activity of the Wnt/β-catenin signalling pathway and the expression of chTERT were both increased after LiCl treatment (Figures 4D and E; p < 0.05), and telomerase activity was also significantly increased (Figure 4F; p < 0.01). These findings further suggested that the β-catenin signalling pathway and chTERT gene can mutually regulate each other and promote the activity/expression of the other.
chTERT promoted the proliferation of LMH cells
As the above results showed that chTERT increases the activity of the Wnt/β-catenin signalling pathway and promotes the expression of Cyclin D1, we postulated that chTERT affects the cell cycle and cell proliferation. To verify this conjecture, the cell cycle was analysed in LMH-chTERT and LMH-NC cells by flow cytometry. The results showed that chTERT overexpression promoted the transition of LMH cells from G1 to S phase and G2 and increased the ratio of S phase cells to G2 cells (Figure 5A; p < 0.001), indicating a reduction in the time required for cell replication, which could theoretically promote cell proliferation. Subsequently, flow cytometry was used to analyse cell proliferation. The results showed that overexpression of chTERT significantly promoted the proliferation of LMH cells (Figure 5B; p < 0.01). The same conclusion was obtained from growth curves for the two kinds of cells in MTT assays (Figures 5C and D; p < 0.05). Finally, Ki67 immunofluorescence staining verified that chTERT could promote the proliferation of LMH cells (Figure 5E).
chTERT inhibited the apoptosis of LMH cells and induced a switch to autophagy
Since regulation of the Wnt/β-catenin signalling pathway by the chTERT gene is often associated with cell growth and development, the effect of chTERT on the apoptosis of LMH cells was explored. The results showed that the mRNA levels of genes that promote apoptosis, such as Caspase 3, Caspase 9 and BAX, were significantly lower in LMH-chTERT cells than in control cells, while the mRNA levels of genes that inhibit apoptosis, such as BCL-2 and BCL-X, were significantly higher than in control cells (Figure 6A; p < 0.05). When the expression of the chTERT or β-catenin gene in LMH-chTERT cells was decreased by si-chTERT or si-β-catenin, similar results were obtained (Figure 6B; p < 0.05). The apoptosis of LMH cells was assessed in detail by flow cytometry, and the results showed that the proportions of early apoptotic, late apoptotic, and necrotic cells were lower in the LMH-chTERT group than in the LMH-NC group (Figure 6C; p < 0.01). In addition, the late apoptosis of LMH cells was analysed by terminal-deoxynucleotidyl transferase-mediated nick end labelling (TUNEL) staining. The proportion of TUNEL-positive cells was lower in the chTERT overexpression group than in the control group (Figure 6D). To verify this finding more intuitively, TEM was performed, and the results showed fewer apoptotic bodies in LMH-chTERT cells than in LMH-NC cells (Figure 7). It is worth noting that there were more autophagosomes in LMH-chTERT cells than in control cells. In addition to indicating that the chTERT gene can inhibit the apoptosis of LMH cells, this finding suggested that overexpression of the chTERT gene promotes the autophagy of LMH cells. These data suggest that chTERT can reduce apoptosis by inducing a switch to autophagy.
chTERT promoted the migration of LMH cells
Our previous study found that chTERT is highly expressed in myeloid tumours caused by ALV-J, which may be related to tumour development and progression . The effect of chTERT on LMH cell migration was analysed in vitro by the wound healing assay. The migration rate of LMH-chTERT cells was significantly higher than that of LMH-NC cells at 24 and 48 h (Figure 8; p < 0.001), indicating that chTERT gene expression enhances the migration ability of LMH cells and indirectly suggesting that chTERT can indeed promote the development and progression of tumours.
chTERT promoted the replication of ALV-J in LMH cells
Since the chTERT gene is highly abundant in myeloid tumours caused by ALV-J, we asked whether it affects ALV-J replication in LMH cells. To answer this question, we assessed the change in chTERT expression in LMH-chTERT and LMH-NC cell pellets before and after infection with ALV-J for 72 h. The cell culture supernatant was collected every day, ALV p27 antigen levels were measured by ELISA, and a growth curve was drawn for ALV-J. The results showed that the expression level of ALV-J was significantly higher in LMH-chTERT cells than in control cells regardless of gp85 mRNA or protein level (Figures 9A and B; p < 0.01). Moreover, the content of ALV-J p27 antigen in the supernatant of LMH-chTERT cells was significantly higher than that in the supernatant of control cells (Figure 9C; p < 0.01), which was consistent with the TCID50 values (Figure 9D; p < 0.05). The above results indicated that chTERT can promote the replication of ALV-J in LMH cells. To explore whether ALV-J can affect the expression of chTERT, LMH-chTERT cells were infected with ALV-J at different MOIs, and an uninfected group was used as a control. The results showed that chTERT expression was significantly higher in cells infected with ALV-J at an MOI of 0.1 or 1.0 than in control cells (Figure 9E and F; p < 0.05) and that telomerase activity was also increased in infected cells, indicating that ALV-J can promote the expression of chTERT. These data indicate that chTERT probably plays an important role in the pathogenesis of ALV-J infection.
Telomerase reverse transcriptase is a key component of telomerase, which plays an important role in maintaining telomere stability and regulating cell growth and development. Telomerase reverse transcriptase has become an important target for the diagnosis and treatment of human tumours [38, 39]. Activation of the hTERT gene is strictly regulated by a variety of signalling pathways in different human tumours, specifically the Wnt/β-catenin, NF-κB and c-Myc signalling pathways [10, 13, 28, 40, 41]. However, during ALV-J-induced tumorigenesis, the molecular mechanism by which the chTERT gene regulates the Wnt/β-catenin signalling pathway and participates in cell growth and virus replication is still unknown. Therefore, exploring the interaction between the chTERT gene and the Wnt/β-catenin signalling pathway is of great significance to obtain an in-depth understanding of the role of chTERT in ALV-induced tumorigenicity.
In this study, the chTERT gene was amplified from muscle tissue of 4- to 7-day-old chicken embryos. Due to the large size of chTERT, the transfection efficiency of chTERT in chicken-derived cell lines is usually extremely low and not sufficient for research. Therefore, an immortal stable chTERT-overexpressing cell line was constructed by transfection with a lentiviral vector. Before a suitable cell line was selected, chTERT gene expression and telomerase activity in the commonly used chicken-derived cell lines DF-1 and LMH were measured. The results showed that DF-1 cells may not express the chTERT gene and are negative for telomerase, but LMH cells express the chTERT gene at a low level and are positive for telomerase (Figure 1B). Therefore, to conduct further comparative experiments, we infected these two cell lines with recombinant lentivirus and screened for DF-1 and LMH cells stably overexpressing the chTERT gene. However, the expression level of chTERT was significantly lower in DF-1 cells overexpressing chTERT than that in LMH-chTERT cells and decreased rapidly as the cells were passaged until chTERT was no longer expressed (data not shown). DF-1 cells are telomerase-negative immortal cells, not cancer cells, and their immortal proliferation does not depend on chTERT but rather on another mechanism, that is, alternative lengthening of telomeres ; this may be why the chTERT gene could not be stably expressed in DF-1 cells. As LMH cells are telomerase-positive cancer cells, the chTERT gene could be stably overexpressed; thus, stable chTERT-overexpressing cells are similar to tumour cells infected with ALV. Therefore, LMH cells were used as the research platform in this study.
This study showed that chTERT can activate the Wnt/β-catenin signalling pathway in LMH cells. Interestingly, after the Wnt/β-catenin signalling pathway was activated by LiCl, the mRNA and protein expression of chTERT and telomerase activity were significantly increased. These data demonstrated that the Wnt/β-catenin signalling pathway can positively regulate chTERT expression. However, whereas the mRNA level of chTERT increased nearly 400-fold in LMH-chTERT cells, the increase in telomerase activity was not as great. First, the TERT mRNA expression level of LMH cells is relatively low, but these cells do have telomerase activity. However, after overexpression of TERT, the mRNA level increased; this is the same thing as having a higher ratio because the denominator is smaller. In this study, telomerase activity was analysed by telomere repeat sequence amplification, a method combining PCR with ELISA. That is, the final results were detected by ELISA after PCR amplification, which led to the change in telomerase activity not being as significant as that in chTERT mRNA expression level. This TRAP method cannot accurately quantify the original telomerase activity but better reflects the trend of change. On the other hand, the obtained results may also stem from a decreased efficiency in translating the foreign HA-labelled TERT gene. The detected protein level of HA-labelled TERT was not as high as expected, and thus, the difference was not as large as that in mRNA levels. This may also explain why the difference in telomerase activity was not as significant as that in the mRNA level. To further confirm that the Wnt/β-catenin signalling pathway can positively regulate chTERT expression, LMH-chTERT cells were transfected with siRNA targeting chTERT. The results were s expected. When the expression of the chTERT gene was inhibited, telomerase activity was reduced, and the activity of the Wnt/β-catenin signalling pathway was significantly decreased. In addition, after the activity of the β-catenin signalling pathway was inhibited by ICG001, IWP-2 and siRNA, the expression of chTERT was significantly reduced, and the activity of telomerase was decreased, further proving the above conclusion. Our results suggested that β-catenin mediates chTERT expression at both the mRNA and protein levels and influences telomerase activity. Moreover, there was a mutually positive regulatory relationship between chTERT and the β-catenin signalling pathway. This finding is consistent with the results of studies on TERT in a variety of human tumours and tumour cells [10, 31, 43].
Many studies have shown that hTERT and β-catenin actively participate in cell growth and development [44, 45] and regulate the development of a variety of human malignancies [46, 47]. To explore whether chTERT and β-catenin play similar roles in LMH cells, we analysed the effect of chTERT on cell growth by CCK-8 assays, RT-PCR, flow cytometry, immunofluorescence staining and TEM. We found that chTERT reduced the number of LMH cells in the G1 phase of the cell cycle and increase the number of cells in S phase and G2; thus, it arrested the cell cycle at S phase, thereby shortening the cell cycle and promoting the proliferation of LMH cells. Moreover, chTERT inhibited the apoptosis of LMH by downregulating the mRNA expression of Caspase 3, Caspase 9 and BAX, which are associated with promoting apoptosis ; by upregulating the mRNA expression of BCL-2 and BCL-X, which are associated with inhibiting apoptosis ; and by promoting autophagy to inhibit apoptosis.
ALV-J can induce apoptosis and inhibit autophagy to slow cell growth [50,51,52]. In this study, the overexpression of chTERT in LMH cells inhibited the apoptosis of ALV-J-infected cells and promoted autophagy, ultimately promoting cell proliferation. Therefore, cells overexpressing chTERT can somewhat offset apoptosis induced by ALV-J infection, which indicates that chTERT can improve the viability of cells infected with ALV-J. Thus, compared with control cells, cells overexpressing chTERT significantly promoted the replication of ALV-J. In addition, this study showed that overexpression of chTERT can enhance the migration ability of LMH cells, which confirms that the migratory activity of tumour cells is better than that of normal cells . Finally, we analysed the effect of ALV-J on the expression of chTERT and found that ALV-J significantly increased chTERT mRNA and protein expression. This finding is consistent with previous research showing that chTERT is a common integration site of ALV-J .
During the replication process of ALV, the sites of its own genome insertion and integration into the host genes are generally random, which is why tumour formation after infection with chronic transformed ALV is relatively rare. However, our previous study showed that in tumours caused by ALV-J, the virus insertion and integration sites were concentrated in the exon regions of the MYC, TERT and Z1C1 genes or upstream of the transcription sites, preliminarily suggesting that the integration of ALV-J in the host genome is actually weakly selective . In this study, we found that chTERT overexpression promoted the replication of ALV-J, mainly because chTERT promotes virus replication by regulating the Wnt/β-catenin signalling pathway to affect cell growth and provide a better environment for ALV-J replication. On the other hand, when chTERT was overexpressed, the probability of ALV-J insertion and integration near chTERT actually increased. Previous studies have shown that the integration of ALV-J upstream of the chTERT gene can lead to an increase in gene transcription . Therefore, if the probability of ALV-J insertion and integration near chTERT increases, the expression of chTERT will also be upregulated. If the MOI of ALV-J is increased at the same time, then this probability will be further increased; thus, the replication of ALV-J will also affect the expression of chTERT. Increased expression of chTERT in turn promotes cell proliferation and inhibits cell apoptosis, thereby providing a better environment for ALV-J replication. However, stronger evidence is needed to ascertain whether chTERT can directly affect the replication ability of the virus itself.
In summary, chTERT and the Wnt/β-catenin signalling pathway can positively regulate each other in LMH cells, inhibiting apoptosis and promoting autophagy by downregulating the mRNA expression of Caspase 3, Caspase 9 and BAX and upregulating BCL-2 and BCL-X expression. In addition, chTERT can shorten the cell cycle to enhance proliferation and ultimately promote cell migration and the replication of ALV-J in LMH cells (Figure 10). Our findings help reveal the role of chTERT in ALV-J-induced oncogenesis.
Availability of data and materials
The data on which the conclusions of the manuscript rely are presented in the main paper.
chicken telomerase reverse transcriptase
human telomerase reverse transcriptase
avian leukosis viruses
avian leukosis virus subgroup J
LMH cells stably overexpressing the chTERT gene
negative control cells for LMH-chTERT
small interfering RNA
telomeric repeat amplification protocol
transmission electron microscopy
enzyme-linked immunosorbent assay
multiplicity of infection
terminal-deoxynucleotidyl transferase-mediated nick end labelling
- TCID50 :
50% Tissue culture infection dose
Stone RC, Aviv A, Paus R (2021) Telomere dynamics and telomerase in the biology of hair follicles and their stem cells as a model for aging research. J Invest Dermatol 141:1031–1040. https://doi.org/10.1016/j.jid.2020.12.006
Delany ME, Krupkin AB, Miller MM (2000) Organization of telomere sequences in birds: evidence for arrays of extreme length and for in vivo shortening. Cytogenet Cell Genet 90:139–145. https://doi.org/10.1159/000015649
Zhang Z, Wang J, Li J, Xu S (2011) Telomerase-mediated apoptosis of chicken lymphoblastoid tumor cell line by lanthanum chloride. Biol Trace Elem Res 144:657–667. https://doi.org/10.1007/s12011-011-9027-8
Casadio V, Bravaccini S (2021) Telomerase activity analysis in urine sediment for bladder cancer. Methods Mol Biol 2292:133–141. https://doi.org/10.1007/978-1-0716-1354-2_12
Bradfield A, Button L, Drury J, Green DC, Hill CJ, Hapangama DK (2020) Investigating the role of telomere and telomerase associated genes and proteins in endometrial cancer. Methods Protoc 3:63. https://doi.org/10.3390/mps3030063
Roggisch J, Ecke T, Koch S (2020) Molecular identification of telomerase reverse transcriptase (TERT) promotor mutations in primary and recurrent tumors of invasive and noninvasive urothelial bladder cancer. Urol Oncol 38:77.e17-77.e25. https://doi.org/10.1016/j.urolonc.2019.08.007
Perera ON, Sobinoff AP, Teber ET, Harman A, Maritz MF, Yang SF, Pickett HA, Cesare AJ, Arthur JW, MacKenzie KL, Bryan TM (2019) Telomerase promotes formation of a telomere protective complex in cancer cells. Sci Adv 5:eaav4409. https://doi.org/10.1126/sciadv.aav4409
Kheimar A, Trimpert J, Groenke N, Kaufer BB (2019) Overexpression of cellular telomerase RNA enhances virus-induced cancer formation. Oncogene 38:1778–1786. https://doi.org/10.1038/s41388-018-0544-1
Maggisano V, Celano M, Lepore SM, Sponziello M, Rosignolo F, Pecce V, Verrienti A, Baldan F, Mio C, Allegri L, Maranghi M, Falcone R, Damante G, Russo D, Bulotta S (2019) Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells. Endocrine 63:545–553. https://doi.org/10.1007/s12020-018-01836-2
Liu J, Wen Y, Luo W, Liu Y, Sha X (2021) Human amniotic epithelial cells promote the proliferation of human corneal endothelial cells by regulating telomerase activity via the Wnt/beta-catenin pathway. Curr Eye Res 46:159–167. https://doi.org/10.1080/02713683.2020.1792508
Yu D, Shang Y, Yuan J, Ding S, Luo S, Hao L (2016) Wnt/beta-catenin signaling exacerbates keloid cell proliferation by regulating telomerase. Cell Physiol Biochem 39:2001–2013. https://doi.org/10.1159/000447896
Jaitner S, Reiche JA, Schaffauer AJ, Hiendlmeyer E, Herbst H, Brabletz T, Kirchner T, Jung A (2012) Human telomerase reverse transcriptase (hTERT) is a target gene of beta-catenin in human colorectal tumors. Cell Cycle 11:3331–3338. https://doi.org/10.4161/cc.21790
Zuo QP, Liu SK, Li ZJ, Li B, Zhou YL, Guo R, Huang LH (2011) NF-kappaB p65 modulates the telomerase reverse transcriptase in the HepG(2) hepatoma cell line. Eur J Pharmacol 672:113–120. https://doi.org/10.1016/j.ejphar.2011.09.187
Wu Y, Bian C, Zhen C, Liu L, Lin Z, Nisar MF, Wang M, Bartsch JW, Huang E, Ji P, Yang L, Yu Y, Yang J, Jiang X, Zhong JL (2017) Telomerase reverse transcriptase mediates EMT through NF-kappaB signaling in tongue squamous cell carcinoma. Oncotarget 8:85492–85503. https://doi.org/10.18632/oncotarget.20888
Baena-Del Valle JA, Zheng Q, Esopi DM, Rubenstein M, Hubbard GK, Moncaliano MC, Hruszkewycz A, Vaghasia A, Yegnasubramanian S, Wheelan SJ, Meeker AK, Heaphy CM, Graham MK, De Marzo AM (2018) MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer. J Pathol 244:11–24. https://doi.org/10.1002/path.4980
Koh CM, Khattar E, Leow SC, Liu CY, Muller J, Ang WX, Li Y, Franzoso G, Li S, Guccione E, Tergaonkar V (2015) Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. J Clin Invest 125:2109–2122. https://doi.org/10.1172/JCI79134
Ren C, Yu M, Zhang Y, Fan M, Chang F, Xing L, Liu Y, Wang Y, Qi X, Liu C, Zhang Y, Cui H, Li K, Gao L, Pan Q, Wang X, Gao Y (2018) Avian leukosis virus subgroup J promotes cell proliferation and cell cycle progression through miR-221 by targeting CDKN1B. Virology 519:121–130. https://doi.org/10.1016/j.virol.2018.04.008
Dai Z, Ji J, Yan Y, Lin W, Li H, Chen F, Liu Y, Chen W, Bi Y, Xie Q (2015) Role of gga-miR-221 and gga-miR-222 during tumour formation in chickens infected by subgroup J avian leukosis virus. Viruses 7:6538–6551. https://doi.org/10.3390/v7122956
Smith LP, Petheridge L, Nair V, Wood A, Welchman D (2018) Avian leukosis virus subgroup J-associated myelocytoma in a hobby chicken. Vet Rec 182:23. https://doi.org/10.1136/vr.104626
Liu P, Li L, Jiang Z, Yu Y, Chen X, Xiang Y, Chen J, Li Y, Cao W (2021) Molecular characteristics of subgroup J avian leukosis virus isolated from yellow breeder chickens in Guangdong, China, during 2016–2019. Infect Genet Evol 89:104721. https://doi.org/10.1016/j.meegid.2021.104721
Cui N, Cui X, Huang Q, Yang S, Su S, Xu C, Li J, Li W, Li C (2020) Isolation and Identification of subgroup J avian leukosis virus inducing multiple systemic tumors in parental meat-type chickens. Front Vet Sci 7:614854. https://doi.org/10.3389/fvets.2020.614854
Li H, Tan M, Zhang F, Ji H, Zeng Y, Yang Q, Tan J, Huang J, Su Q, Huang Y, Kang Z (2021) Diversity of avian leukosis virus subgroup J in local chickens, Jiangxi, China. Sci Rep 11:4797. https://doi.org/10.1038/s41598-021-84189-7
Yang F, Xian RR, Li Y, Polony TS, Beemon KL (2007) Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomas. Proc Natl Acad Sci U S A 104:18952–18957. https://doi.org/10.1073/pnas.0709173104
Li Y, Liu X, Yang Z, Xu C, Liu D, Qin J, Dai M, Hao J, Feng M, Huang X, Tan L, Cao W, Liao M (2014) The MYC, TERT, and ZIC1 genes are common targets of viral integration and transcriptional deregulation in avian leukosis virus subgroup J-induced myeloid leukosis. J Virol 88:3182–3191. https://doi.org/10.1128/JVI.02995-13
Kar S, Jasuja H, Katti DR, Katti KS (2020) Wnt/beta-catenin signaling pathway regulates osteogenesis for breast cancer bone metastasis: experiments in an in vitro nanoclay scaffold cancer testbed. ACS Biomater Sci Eng 6:2600–2611. https://doi.org/10.1021/acsbiomaterials.9b00923
Li X, Xiang Y, Li F, Yin C, Li B, Ke X (2019) WNT/beta-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment. Front Immunol 10:2293. https://doi.org/10.3389/fimmu.2019.02293
Tong X, Zhuang Z, Wang X, Yang X, Bai L, Su L, Wei P, Su X (2021) ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway. Biomed Pharmacother 137:111209. https://doi.org/10.1016/j.biopha.2020.111209
Yang F, Guo Z, He C, Qing L, Wang H, Wu J, Lu X (2021) Cancer-associated fibroblasts promote cell proliferation and invasion via paracrine Wnt/IL1beta signaling pathway in human bladder cancer. Neoplasma 68:79–86. https://doi.org/10.4149/neo_2020_200202N101
He X, Meng F, Yu ZJ, Zhu XJ, Qin LY, Wu XR, Liu ZL, Li Y, Zheng YF (2021) PLCD1 suppressed cellular proliferation, invasion, and migration via inhibition of Wnt/beta-catenin signaling pathway in esophageal squamous cell carcinoma. Dig Dis Sci 66:442–451. https://doi.org/10.1007/s10620-020-06218-1
Dong Q, Jie Y, Ma J, Li C, Xin T, Yang D (2021) Wnt/beta-catenin signaling pathway promotes renal ischemia-reperfusion injury through inducing oxidative stress and inflammation response. J Recept Signal Transduct Res 41:15–18. https://doi.org/10.1080/10799893.2020.1783555
Chen S, Yang L, Dong H, Guo H (2019) Human telomerase reverse transcriptase recruits the beta-catenin/TCF-4 complex to transactivate chemokine (C-C motif) ligand 2 expression in colorectal cancer. Biomed Pharmacother 112:108700. https://doi.org/10.1016/j.biopha.2019.108700
Listerman I, Gazzaniga FS, Blackburn EH (2014) An investigation of the effects of the core protein telomerase reverse transcriptase on Wnt signaling in breast cancer cells. Mol Cell Biol 34:280–289. https://doi.org/10.1128/MCB.00844-13
Zhang Y, Toh L, Lau P, Wang X (2012) Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/beta-catenin pathway in human cancer. J Biol Chem 287:32494–32511. https://doi.org/10.1074/jbc.M112.368282
Wang W, Zhang T, Wu C, Wang S, Wang Y, Li H, Wang N (2017) Immortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR. PLoS One 12:e0177348. https://doi.org/10.1371/journal.pone.0177348
Ding L, Jiang Z, Wu J, Li D, Wang H, Lu W, Zeng Q, Xu G (2019) betacatenin signalling inhibits cartilage endplate chondrocyte homeostasis in vitro. Mol Med Rep 20:567–572. https://doi.org/10.3892/mmr.2019.10301
Hiyama A, Sakai D, Risbud MV, Tanaka M, Arai F, Abe K, Mochida J (2010) Enhancement of intervertebral disc cell senescence by WNT/beta-catenin signaling-induced matrix metalloproteinase expression. Arthritis Rheum 62:3036–3047. https://doi.org/10.1002/art.27599
Kawasaki K, Kuboki S, Furukawa K, Takayashiki T, Takano S, Ohtsuka M (2021) LGR5 induces beta-catenin activation and augments tumour progression by activating STAT3 in human intrahepatic cholangiocarcinoma. Liver Int 41:865–881. https://doi.org/10.1111/liv.14747
Pestana A, Vinagre J, Sobrinho-Simoes M, Soares P (2017) TERT biology and function in cancer: beyond immortalisation. J Mol Endocrinol 58:R129–R146. https://doi.org/10.1530/JME-16-0195
Relitti N, Saraswati AP, Federico S, Khan T, Brindisi M, Zisterer D, Brogi S, Gemma S, Butini S, Campiani G (2020) Telomerase-based cancer therapeutics: a review on their clinical trials. Curr Top Med Chem 20:433–457. https://doi.org/10.2174/1568026620666200102104930
Shen Y, Xi F, Li H, Luo Y, Chen C, Wang L (2018) Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancer. IUBMB Life 70:642–648. https://doi.org/10.1002/iub.1758
Long C, Xu QB, Ding L, Yang L, Ji W, Gao F, Ji Y (2021) Triptolide inhibits human telomerase reverse transcriptase by downregulating translation factors SP1 and c-Myc in Epstein-Barr virus-positive B lymphocytes. Oncol Lett 21:280. https://doi.org/10.3892/ol.2021.12541
O’Hare TH, Delany ME (2011) Molecular and cellular evidence for the alternative lengthening of telomeres (ALT) mechanism in chicken. Cytogenet Genome Res 135:65–78. https://doi.org/10.1159/000330125
Fathi E, Valipour B, Sanaat Z, Nozad Charoudeh H, Farahzadi R (2020) Interleukin-6, -8, and TGF-beta secreted from mesenchymal stem cells show functional role in reduction of telomerase activity of leukemia cell via Wnt5a/beta-catenin and P53 pathways. Adv Pharm Bull 10:307–314. https://doi.org/10.34172/apb.2020.037
Xu C, Xie N, Su Y, Sun Z, Liang Y, Zhang N, Liu D, Jia S, Xing X, Han L, Li G, Tong T, Chen J (2020) HnRNP F/H associate with hTERC and telomerase holoenzyme to modulate telomerase function and promote cell proliferation. Cell Death Differ 27:1998–2013. https://doi.org/10.1038/s41418-019-0483-6
Du J, Liu H, Mao X, Qin Y, Fan C (2021) ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/beta-catenin signaling. Int J Med Sci 18:1442–1448. https://doi.org/10.7150/ijms.43167
Xie W, Liu N, Wang X, Wei L, Xie W, Sheng X (2021) Wilms’ tumor 1-associated protein contributes to chemo-resistance to cisplatin through the Wnt/beta-catenin pathway in endometrial cancer. Front Oncol 11:598344. https://doi.org/10.3389/fonc.2021.598344
Salimi-Jeda A, Badrzadeh F, Esghaei M, Abdoli A (2021) The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches. Cancer Treat Res Commun 27:100323. https://doi.org/10.1016/j.ctarc.2021.100323
Xu Y, Li Z, Zhang S, Zhang H, Teng X (2020) miR-187-5p/apaf-1 axis was involved in oxidative stress-mediated apoptosis caused by ammonia via mitochondrial pathway in chicken livers. Toxicol Appl Pharmacol 388:114869. https://doi.org/10.1016/j.taap.2019.114869
Zhang K, Zhu Y, Wang X, Zhao X, Li S, Teng X (2017) Excess manganese-induced apoptosis in chicken cerebrums and embryonic neurocytes. Biol Trace Elem Res 180:297–305. https://doi.org/10.1007/s12011-017-0992-4
Liao Z, Zhang X, Song C, Lin W, Cheng Y, Xie Z, Chen S, Nie Y, Li A, Zhang H, Li H, Li H, Xie Q (2020) ALV-J inhibits autophagy through the GADD45beta/MEKK4/P38MAPK signaling pathway and mediates apoptosis following autophagy. Cell Death Dis 11:684. https://doi.org/10.1038/s41419-020-02841-y
Ren C, Xie R, Yao Y, Yu M, Chang F, Xing L, Zhang Y, Liu Y, Wang S, Farooque M, Wang Y, Qi X, Liu C, Zhang Y, Cui H, Li K, Gao L, Pan Q, Nair V, Wang X, Gao Y (2019) MiR-125b suppression inhibits apoptosis and negatively regulates Sema4D in avian leukosis virus-transformed cells. Viruses 11:728. https://doi.org/10.3390/v11080728
Liu D, Dai M, Zhang X, Cao W, Liao M (2016) Subgroup J avian leukosis virus infection of chicken dendritic cells induces apoptosis via the aberrant expression of microRNAs. Sci Rep 6:20188. https://doi.org/10.1038/srep20188
Sanyal S, Mondal P, Sen S, Sengupta Bandyopadhyay S, Das C (2020) SUMO E3 ligase CBX4 regulates hTERT-mediated transcription of CDH1 and promotes breast cancer cell migration and invasion. Biochem J 477:3803–3818. https://doi.org/10.1042/BCJ20200359
Jin K, Chen H, Zuo Q, Huang C, Zhao R, Yu X, Wang Y, Zhang Y, Chang Z, Li B (2018) CREPT and p15RS regulate cell proliferation and cycling in chicken DF-1 cells through the Wnt/beta-catenin pathway. J Cell Biochem 119:1083–1092. https://doi.org/10.1002/jcb.26277
Swanberg SE, Payne WS, Hunt HD, Dodgson JB, Delany ME (2004) Telomerase activity and differential expression of telomerase genes and c-myc in chicken cells in vitro. Dev Dyn 231:14–21. https://doi.org/10.1002/dvdy.20149
Chen M, Li X, Fan R, Cao C, Yao H, Xu S (2017) Selenium antagonizes cadmium-induced apoptosis in chicken spleen but not involving Nrf2-regulated antioxidant response. Ecotoxicol Environ Saf 145:503–510. https://doi.org/10.1016/j.ecoenv.2017.08.001
Dai M, Feng M, Liu D, Cao W, Liao M (2015) Development and application of SYBR Green I real-time PCR assay for the separate detection of subgroup J Avian leukosis virus and multiplex detection of avian leukosis virus subgroups A and B. Virol J 12:52. https://doi.org/10.1186/s12985-015-0291-7
We would like to thank Professor Ming Liao (South China Agriculture University) for providing the 293T cells and LMH cells, Avian Disease and Oncology Laboratory (USA) for providing the mouse monoclonal antibodies (G2.3) against the gp85 protein of ALV-J, and Springer Nature Author Services for editing the manuscript for proper English language, grammar, and spelling.
This study was supported by the Key-Area Research and Development Program of Guangdong Province (2020B020222001), the National Key R&D Project (2016YFD0501606), the Poultry Industry Technology System of Guangdong (2020KJ128), and the China Agriculture Research System of MOF and MARA (CARS-41).
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Xiang, Y., Yu, Y., Li, Q. et al. Mutual regulation between chicken telomerase reverse transcriptase and the Wnt/β-catenin signalling pathway inhibits apoptosis and promotes the replication of ALV-J in LMH cells. Vet Res 52, 110 (2021). https://doi.org/10.1186/s13567-021-00979-x
- chicken telomerase reverse transcriptase
- Wnt/β-catenin signalling pathway
- cell proliferation
- avian leukosis virus subgroup J